PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan.\', \'Department of Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.\', \'Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.\', \'Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Yongkang District, Tainan, Taiwan.\', \'Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.\', \'Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. cmcvecho2@gmail.com.\', \'Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, 901, Zhonghua Road, Yongkang District, Tainan, Taiwan. cmcvecho2@gmail.com.\', \'Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan. cmcvecho2@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10557-020-07024-7
?:hasPublicationType
?:journal
  • Cardiovascular drugs and therapy
is ?:pmid of
?:pmid
?:pmid
  • 32557011
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.349
?:rankingScore_hIndex
  • 61
?:title
  • A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all